BIOJECT MEDICAL (OTC:BJCT)
Industry: Healthcare

Bioject Medical Technologies Inc., together with its subsidiaries, develops, manufactures, and distributes needle-free injection therapy systems for the pharmaceutical and biotech industries in the United States. Its needle-free injection products include Biojector 2000 system that delivers intramuscular, subcutaneous, and intradermal injections; ZetaJet system, which provides vaccines and injectable medications either subcutaneously or intramuscularly for professional and home use; and a needle-free drug reconstitution system, which allows the transfer of diluents to reconstitute powdered medications into liquid form and withdrawal of liquid medication into a syringe without the use of a needle. It also offers a needle-free drug reconstitution vial adapter, a plastic device that replaces a fill needle for accessing medication vials making syringe filling completely needle-free. In addition, the company is developing Intradermal Pen spring-powered needle-free injector; Iject gas-powered and versatile injection systems; Jupiter Jet, a hand-held device for administering small volumes of drugs; and multi-port orifices for intradermal injections. Bioject Medical Technologies Inc. was founded in 1985 and is based in Tigard, Oregon.

Current Quote*
Last: $Unk
Change: 0.000
Book: $Unk
Volume: Unk

As Of: 04/18 14:44 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol BJCT

  • No BuyIns.Net Alerts Available for BJCT

Graphs for BJCT


3 Month Graph


6 Month Graph


1 Year Graph